Vitamin A Decreases Cytotoxicity of Oxidized Low-Density Lipoprotein in Patients with Atherosclerosis

References

• Abtahi Froushani SM, Delirezh N, Hobbenaghi R, Mosayebi G. (2014). Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis. Immunol Invest, 43(1), 54–68.
   PubMed Web of Science ®Google Scholar
• Alcouffe J, Caspar-Bauguil S, Garcia V, et al. (1999). Oxidized low density lipoproteins induce apoptosis in PHA-activated peripheral blood mononuclear cells and in the Jurkat T-cell line. J Lipid Res, 40(7), 1200–10.
   PubMed Web of Science ®Google Scholar
• Alwan A. (2011). Global status report on noncommunicable diseases 2010. Geneva, Switzerland: World Health Organization.
   Google Scholar
• Anselmi M, Garbin U, Agostoni P, et al. (2006). Plasma levels of oxidized-low-density lipoproteins are higher in patients with unstable angina and correlated with angiographic coronary complex plaques. Atherosclerosis, 185(1), 114–20.
   PubMed Web of Science ®Google Scholar
• Ashidate K, Kawamura M, Tohda H, et al. (2002). Ascorbic acid augments cytotoxicity induced by oxidized low-density lipoprotein. J Atheroscler Thromb, 10(1), 7–12.
   Google Scholar
• Belcher JD, Balla J, Balla G, et al. (1993). Vitamin E, LDL, and endothelium. Brief oral vitamin supplementation prevents oxidized LDL-mediated vascular injury in vitro. Arterioscler Thromb Vasc Biol, 13(12), 1779–89.
   PubMed Web of Science ®Google Scholar
• Berliner JA, Heinecke JW. (1996). The role of oxidized lipoproteins in atherogenesis. Free Radical Biol Med, 20(5), 707–27. doi: http://dx.doi.org/10.1016/0891-5849(95)02173-6.
   PubMed Web of Science ®Google Scholar
• Blomhoff HK. (2004). Vitamin A regulates proliferation and apoptosis of human T-and B-cells. Biochem Soc Trans, 32(6), 982–84.
   PubMed Web of Science ®Google Scholar
• Boushehri SN, Yusof RM, Taib MNM, et al. (2012). Effect of vitamin supplementation on serum oxidized low-density lipoprotein levels in male subjects with cardiovascular disease risk factors. Iran J Basic Med Sci, 15(4), 958.
   PubMed Web of Science ®Google Scholar
• Dedoussis GVZ, Kaliora AC, Psarras S, et al. (2004). Antiatherogenic effect of Pistacia lentiscus via GSH restoration and downregulation of CD36 mRNA expression. Atherosclerosis, 174(2), 293–303.
   PubMed Web of Science ®Google Scholar
• Engedal N, Ertesvag A, Blomhoff HK. (2004). Survival of activated human T lymphocytes is promoted by retinoic acid via induction of IL‐2. Int Immunol, 16(3), 443–53.
   PubMed Web of Science ®Google Scholar
• Epstein FH, Ross R. (1999). Atherosclerosis—an inflammatory disease. N Engl J Med, 340(2), 115–26.
   PubMed Web of Science ®Google Scholar
• Ermak N, Lacour B, Drüeke TB, Vicca S. (2008). Role of reactive oxygen species and Bax in oxidized low density lipoprotein-induced apoptosis of human monocytes. Atherosclerosis, 200(2), 247–56.
   PubMed Web of Science ®Google Scholar
• Ertesvag A, Engedal N, Naderi S, Blomhoff HK. (2002). Retinoic acid stimulates the cell cycle machinery in normal T cells: Involvement of retinoic acid receptor-mediated IL-2 secretion. J Immunol, 169(10), 5555–563.
   PubMed Web of Science ®Google Scholar
• Fortun A, Khalil A, Gagné D, et al. (2001). Monocytes influence the fate of T cells challenged with oxidised low density lipoproteins towards apoptosis or MHC-restricted proliferation. Atherosclerosis, 156(1), 11–21.
   PubMed Web of Science ®Google Scholar
• Frostegård J, Wu R, Giscombe R, et al. (1992). Induction of T-cell activation by oxidized low density lipoprotein. Arterioscler Thromb Vasc Biol, 12(4), 461–67.
   PubMed Web of Science ®Google Scholar
• Gokulakrishnan K, Deepa R, Velmurugan K, et al. (2007). Oxidized low-density lipoprotein and intimal medial thickness in subjects with glucose intolerance—The Chennai Urban Rural Epidemiology Study-25. Metabolism, 56(2), 245–50.
   PubMed Web of Science ®Google Scholar
• Han C-Y, Pak YK. (1999). Oxidation-dependent effects of oxidized LDL: Proliferation or cell death. Exp Mol Med, 31(4), 165–73.
   PubMed Web of Science ®Google Scholar
• Harris LK, Mann GE, Ruiz E, et al. (2006). Ascorbate does not protect macrophages against apoptosis induced by oxidised low density lipoprotein. Arch Biochem Biophys, 455(1), 68–76.
   PubMed Web of Science ®Google Scholar
• Holvoet P, Macy E, Landeloos M, et al. (2006). Analytical performance and diagnostic accuracy of immunometric assays for the measurement of circulating oxidized LDL. Clin Chem, 52(4), 760–64.
   PubMed Web of Science ®Google Scholar
• Holvoet P, Vanhaecke J, Janssens S, et al. (1998). Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation, 98(15), 1487–94.
   PubMed Web of Science ®Google Scholar
• Huang YH, Rönnelid J, Frostegård J. (1995). Oxidized LDL induces enhanced antibody formation and MHC class II–dependent IFN-γ production in lymphocytes from healthy individuals. Arterioscler Thromb Vasc Biol, 15(10), 1577–83.
   PubMed Web of Science ®Google Scholar
• Hunt KJ, Baker NL, Cleary P, et al. (2012). Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid IMT in type 1 diabetes. Circulation, 125(10 Supplement), A019.
   Google Scholar
• Jafarirad S, Siassi F, Harirchian M-H, et al. (2013). The effect of vitamin a supplementation on biochemical parameters in multiple sclerosis patients. Iran Red Crescent Med J, 15(3), 194.
   PubMed Web of Science ®Google Scholar
• Keaney JF Jr, Guo Y, Cunningham D, et al. (1996). Vascular incorporation of alpha-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation. J Clin Invest, 98(2), 386.
   PubMed Web of Science ®Google Scholar
• Kwak B, Mulhaupt F, Myit S, Mach F. (2000). Statins as a newly recognized type of immunomodulator. Nat Med, 6(12), 1399–02.
   PubMed Web of Science ®Google Scholar
• Lopes-Virella MF, Hunt KJ, Baker NL, et al. (2011). Levels of oxidized LDL and advanced glycation end products–modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetes. Diabetes, 60(2), 582–89.
   PubMed Web of Science ®Google Scholar
• Mahmoudi M, Siassi F, Mahmoudi MJ, et al. (2010). Defective T-cell proliferation and IL-2 production in a subgroup of patients with coronary artery disease. Iran J Allergy Asthma Immunol, 9(3), 133–40.
   PubMed Web of Science ®Google Scholar
• Mahmoudi MJ, Mahmoudi M, Siassi F, et al. (2011). Lymphocyte cytotoxicity of oxLDL in patients with atherosclerosis. Iran J Immunol, 8(1), 27–33.
   PubMed Web of Science ®Google Scholar
• Malek TR. (2003). The main function of IL-2 is to promote the development of T regulatory cells. J Leukocyte Biol, 74(6), 961–65.
   PubMed Web of Science ®Google Scholar
• Marchant CE, Law NS, van der Veen C, et al. (1995). Oxidized low-density lipoprotein is cytotoxic to human monocyte-macrophages: protection with lipophilic antioxidants. FEBS Lett, 358(2), 175–78.
   PubMed Web of Science ®Google Scholar
• Martinet W, Kockx MM. (2001). Apoptosis in atherosclerosis: Focus on oxidized lipids and inflammation. Curr Opin Lipidol, 12(5), 535–41.
   PubMed Web of Science ®Google Scholar
• Meraji S, Abuja PM, Hayn M, et al. (2000). Relationship between classic risk factors, plasma antioxidants and indicators of oxidant stress in angina pectoris (AP) in Tehran. Atherosclerosis, 150(2), 403–12.
   PubMed Web of Science ®Google Scholar
• Meraji S, Ziouzenkova O, Resch U, et al. (1997). Enhanced plasma level of lipid peroxidation in Iranians could be improved by antioxidants supplementation. Eur J Clin Nutr, 51, 318–25.
   PubMed Web of Science ®Google Scholar
• Morrissey PA, Kiely M. (2006). Oxysterols: Formation and biological function. In: Fox PF, McSweeney PLH, eds. Advanced Dairy Chemistry Volume 2 Lipids. New York, NY: Springer, 641–74.
   Google Scholar
• Nozaki Y, Tamaki C, Yamagata T, et al. (2006). All-trans-retinoic acid suppresses interferon-γ and tumor necrosis factor-α; a possible therapeutic agent for rheumatoid arthritis. Rheumatol Int, 26(9), 810–17.
   PubMed Web of Science ®Google Scholar
• Ono K. (2012). Current concept of reverse cholesterol transport and novel strategy for atheroprotection. J Cardiol, 60(5), 339–43.
   PubMed Web of Science ®Google Scholar
• Orchard TJ, Virella G, Forrest KY, et al. (1999). Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: A nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes, 48(7), 1454–58.
   PubMed Web of Science ®Google Scholar
• Palace VP, Khaper N, Qin Q, Singal PK. (1999). Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease. Free Radical Biol Med, 26(5), 746–61.
   PubMed Web of Science ®Google Scholar
• Rutkowski M, Grzegorczyk K. (2012). Adverse effects of antioxidative vitamins. Int J Occup Med Environ Health, 25(2), 105–21.
   PubMed Web of Science ®Google Scholar
• Salvayre R, Auge N, Benoist H, Negre-Salvayre A. (2002). Oxidized low-density lipoprotein-induced apoptosis. Biochim Biophys Acta, Mol Cell Biol Lipids, 1585 (2–3), 213–21. doi:10.1016/S1388-1981(02)00343-8.
   PubMed Web of Science ®Google Scholar
• Seppo, L, Lähteenmäki T, Tikkanen MJ, et al. (2005). Effects of vitamin E on the toxicity of oxidized LDL on endothelial cells in vitro in smokers vs nonsmokers on diets rich in fish. Eur J Clin Nutr, 59(11), 1282–90.
   PubMed Web of Science ®Google Scholar
• Sezavar H, Saboor-Yaraghi A-A, Salehi E, Mottaghi A. (2015). Whether vitamin A supplementation is effective in T-bet and IFN-ɣ gene expression reduction? Immunol Invest, 44(2), 189–98.
   PubMed Web of Science ®Google Scholar
• Shaish A, Daugherty AFOS, O’Sullivan F, et al. (1995). Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits. J Clin Invest, 96(4), 2075.
   PubMed Web of Science ®Google Scholar
• Viora M, Straface E, Di Genova G, et al. (1997). Oxidized low density lipoproteins impair peripheral blood mononuclear cell proliferation and cytokine production. Biochem Biophys Res Commun, 232(2), 359–63.
   PubMed Web of Science ®Google Scholar
• Voutilainen S, Nurmi T, Mursu J, Rissanen TH. (2006). Carotenoids and cardiovascular health. Am J Clin Nutr, 83(6), 1265–71.
   PubMed Web of Science ®Google Scholar
• Wang M-D, Franklin V, Marcel YL. (2007a). In vivo reverse cholesterol transport from macrophages lacking ABCA1 expression is impaired. Arterioscler Thromb Vasc Biol, 27(8), 1837–42.
   PubMed Web of Science ®Google Scholar
• Wang X, Collins HL, Ranalletta M, et al. (2007b). Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J Clin Invest, 117(8), 2216.
   PubMed Web of Science ®Google Scholar